BioSpace News Archive

HCP transparency, feeling prepared with all possible information decrease regret over treatment decisions

A new report released today on Medicare Part D found the program is as popular and robust as ever, but poses significant challenges to beneficiaries that result in increased out-of-pocket costs and limited access for millions of beneficiaries.

New England Biolabs (NEB®) has announced an invitation for scientists to submit entries for the 2019 Passion in Science Awards.

Transgene (Paris:TNG) today announced its financial reporting dates for 2019

The National Institutes of Health’s Monitoring the Future Study (MTF), an annual survey tracking substance use among nearly 45,000 8th, 10th and 12th graders, shows a dramatic increase in American teens’ use of vaping devices in just a single year – with 37.3 percent of 12th graders reporting “any vaping” in the past 12 months, compared to just 27.8 percent in 2017.

I’m a nurse and I thought there could be a better way to cover a wound and prevent it from leaking,” said one of two inventors, from Bethany, Ill., “so we invented the K A SORBER.”

Today Lexogen launches a Version 2 (V2) upgrade for the TeloPrime Full-Length cDNA Amplification Kit; an all-in-one protocol for generating 5' cap-specific full-length cDNA from as little as 1 ng of total RNA.

In a first-in-human clinical trial reported today in Blood, the investigational drug sutimlimab appeared to be effective in treating cold agglutinin disease, a rare chronic blood disorder for which there are currently no approved treatments.

The Canadian Drug Insurance Pooling Corporation (CDIPC) advised today that in 2017, through its sharing framework for high-cost drugs, the private insurance industry has helped keep drug benefits affordable for more than 11,800 small and mid-size employers.

Available in the mobile App and in an abridged format for primary care providers, key Standards of Care updates include new treatment decision pathways, options to decrease cardiovascular disease risk, and a new section on the use of technology